The effect of hemoperfusion on the recovery of COVID-19 in hospitalized patients;case series and review study
Immunopathologia Persa
; 7(2):4, 2021.
Article
in English
| Web of Science | ID: covidwho-1332548
ABSTRACT
Hemoperfusion is an effective modality in removing certain toxins from the blood, especially those that bind to proteins in the body. Hemoperfusion has shown a therapeutic effect on COVID-19 patients. In this case series, we report four patients without effective results following the use of hemoperfusion on the recovery of COVID-19 patients. This study is a case series which carried out on four patients referred to COVID-19 ward of Velayat hospital in Qazvin, Iran. The mean age of the COVID-19 patients was 52.75 +/- 18 years. The mean stay at the hospital was 21.5 +/- 15.15 days. This study showed that hemoperfusion cannot show a significant therapeutic effect on COVID-19.
Full text:
Available
Collection:
Databases of international organizations
Database:
Web of Science
Type of study:
Experimental Studies
Language:
English
Journal:
Immunopathologia Persa
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS